peptide · regulated markets
Peptide Affiliate vs Paid Rates: When Each One Wins
Last Thursday a GLP-1 telehealth founder asked me whether to pay More Plates More Dates (a 2M-subscriber YouTube channel on performance enhancement, run by Derek, also called MPMD) a $5,000 flat fee or push a 20 percent commission affiliate-only deal. A peptide is a short chain of amino acids; some are sold as recovery products. GLP-1 (glucagon-like peptide-1) is the class of weight-loss drugs like Ozempic and Mounjaro. The 90-second answer was flat. Here is the 5-minute version.
MPMD has run 56 peptide-relevant ads since January 2024 across Marek Health (a US testosterone and peptide telehealth clinic), Gorilla Mind (a supplement brand he co-founded), B-Team Junkies, and Peter Attia (a longevity-medicine podcast host). That is one paid placement every 11 days. Brands paying him buy retainer slots.
In our database we track 210 Marek Health deals across 32 creators from January 2024 to April 2026. The brands running the longest peptide-creator partnerships use flat fee or hybrid flat-plus-commission. Pure affiliate shows up at the edge, not at scale.
Where the flip line actually sits
The flip line is the creator-AOV point where 20 percent of one post's expected affiliate revenue beats the creator's flat-fee floor. AOV means average order value. Below the line, the creator wants flat. Above it, the creator entertains commission.
That line sits in a different place for testosterone brands than for GLP-1 brands than for BPC stack brands. BPC-157 is a short peptide some athletes use for soft-tissue recovery. AOV per customer differs by three to five times across the three peptide sub-verticals.
The flip moves on three inputs. Creator post volume. Peptide sub-vertical AOV. Audience-to-category fit. Miss one and the cheap affiliate deal becomes the worst spend on the roster, which is why we map the flip line per creator before any rate gets quoted.
How the math changes across TRT, GLP-1, and BPC
Level 1 is TRT (testosterone replacement therapy). AOV per customer runs $150 to $300 per month on a six-month average lifetime. One customer is worth roughly $1,200 in lifetime value. A 20 percent commission on that LTV is $240. Against five signups per post that gives the creator $1,200 per post. That falls below most TRT-friendly creators' flat-fee floors.
Level 2 is GLP-1. AOV per customer runs $400 to $700 per month because the meds carry markup. Lorraine Kamesha, a 59K-subscriber GLP-1 weight-loss creator, ran 22 Orderly Meds deals as the named anchor in our log. Orderly Meds is a GLP-1 telehealth brand. The flip line is lower than TRT because each customer carries more value.
Level 3 is BPC-157 and research-peptide stacks. The first-order ticket is often a multi-vial stack. The math reads best for the creator. But the regulatory layer is the hardest of the three, which shrinks the creator pool.
Not sure which sub-vertical your AOV math sits in? The flip line moves with creator post volume, peptide category, and audience-to-product fit. Get the wrong read and the cheap affiliate deal turns into the worst spend on the roster. We map the math against your real AOV and our peptide-creator history before the first email goes out.
Send us your brief and we'll map the flip line →Why the top tier refuses pure affiliate
The MPMD-tier creator has enough deal volume that one always-on retainer slot beats commission upside on a single post. Inbound deal flow is dense enough that they do not bet on conversion outcomes they cannot audit.
Would a top creator take affiliate-only if the brand sweetened the commission to 35 percent. Almost never. The brand still controls the attribution dashboard, the discount-code reporting cadence, and the kill-the-deal-anytime clause. The creator's downside on a 90-second on-camera read is the same whether the payout is $0 or $5,000.
Mark Bell's Power Project at 384K subscribers ran 20 Marek Health deals from December 2025 to April 2026. That is four deals a month for five months. VigorousClips ran 44 Marek deals in the same window. Both rates are flat. Both have already spread their legal-review costs across their own catalog. Neither needs the affiliate upside, which is why we send peptide brands the deal-cadence read free before any outreach.
Vetting is the work.
- Affiliate-only deals that look free and produce zero signups on nine of ten posts
- Flat fees paid to creators whose audience does not convert for your sub-vertical
- Hybrid splits with commission caps that quietly clip the creator's upside in month two
Across 210 Marek Health deals and 32 creators in our sponsor log, the brands running the longest creator partnerships use flat or hybrid, not pure affiliate. Pure affiliate shows up at the new-brand edge, not at scale.— Internal sponsor-deal log, Jan 2024 to Apr 2026Send me the deal-shape read, free →
The four deal shapes we see in our log
Archetype 1 is the flat-fee retainer. The brand pays a monthly cash rate for a fixed number of posts. No commission. Marek Health's 210 deals across 32 creators is the textbook case. Predictable inventory. No attribution disputes. MPMD and Mark Bell's Power Project both sit here.
Archetype 2 is the hybrid flat-plus-commission. The brand pays a smaller flat ($1,500 to $3,500 per post) plus 10 to 20 percent commission on code-tracked signups. Roseland Lashay ran 19 Mochi Health deals and Lorraine Kamesha ran 22 Orderly Meds deals. Mochi Health is a GLP-1 weight-loss telehealth brand. Both cohorts use code-driven attribution with a hybrid base, here is the hybrid-split template we send brands.
Archetype 3 is bounty-per-signup. The brand pays a flat dollar amount per attributed signup with no flat floor. We see this on mid-tail patient-advocate creators under 50K subscribers, where audience-product fit is tight enough to predict per-post signups within a narrow range.
Archetype 4 is pure affiliate. Commission only. No cash up front. Almost nobody above 200K subscribers takes it. Below 200K, the discount-code-driven pool will. This archetype looks free and produces nine zero-signup posts for every one winner.
Pick the cadence before the rate. Pick the rate before the structure.
What affiliate-only quietly misses
Affiliate alone misses the creator's incentive to give the brand a deeper integration. A flat-fee creator will spend the extra 20 minutes writing a custom hook. They will reshoot the on-camera testimonial if the lighting is bad. They will route audience questions to the brand's intake form. An affiliate-only creator does the minimum because their downside is bounded at zero.
It also misses the on-camera consistency that builds trust over multiple insertions. Marek Health's 210 deals across 32 creators compound because the same creators repeat the brand name in the same register for months. The FDA's September 2025 warning-letter sweep against 30 telehealth companies marketing compounded GLP-1s shows why consistent creator-side language matters. A creator on a flat retainer rereads the brief. A creator on pure commission usually does not.
Where We Come In
We run the affiliate-versus-paid math on every peptide brief before the first email goes out. Per-creator deal history, sub-vertical AOV bands, and past affiliate-versus-flat splits already live in our database. The downside of the wrong structure on one post is bounded at the post cost. The upside of the right one on a 12-month slot compounds into the pattern Marek has built across 32 creators. The FDA's bulks-list rules for compounded peptides make the compliance tail worse when the creator pool churns. Speak with us when you want the deal structured before the rate gets quoted.
Structure beats rate.
FAQ
When does an affiliate-only peptide deal beat a $5K flat fee?
Almost never above 200K subscribers. Below that, only when the creator runs a tight category match. The math flips when one customer is worth $400 or more per month and the creator can drive five or more signups per post. GLP-1 brands hit that line. Plain TRT brands rarely do.
Why won't top-tier peptide creators take affiliate-only deals?
They have enough inbound flow that one always-on retainer slot beats commission upside on a single post. They cannot audit the attribution dashboard the brand controls. Downside on a 90-second on-camera read is the same whether the payout is $0 or $5,000. Flat fee removes that risk.
What does the hybrid flat-plus-commission deal look like?
A smaller flat fee, often $1,500 to $3,500 per post, plus a 10 to 20 percent commission on code-tracked signups. Roseland Lashay's 19 Mochi Health deals and Lorraine Kamesha's 22 Orderly Meds deals are the named anchors in our GLP-1 data. Both run on code-driven attribution with a hybrid base.
Reading loop
- Hub: peptide influencer marketing
- Related: BPC-157 creator rates, peptide retainer vs one-off cadence
- Compliance: peptide FTC warning letters analysis
Frequently asked
When does an affiliate-only peptide deal beat a $5K flat fee?
Almost never above 200K subscribers. Below that, only when the creator runs a tight category match. The math flips when one converted customer is worth $400 or more per month and the creator can drive five or more signups per post. GLP-1 brands hit that line. Plain TRT brands rarely do.
Why won't top-tier peptide creators take affiliate-only deals?
They have enough inbound deal flow that one always-on retainer slot beats commission upside on a single post. They cannot audit the attribution dashboard the brand controls. The downside risk on a 90-second on-camera read is the same whether the payout is $0 or $5,000. Flat fee removes that risk for them.
What does the hybrid flat-plus-commission deal look like?
A smaller flat fee, often $1,500 to $3,500 per post, plus a 10 to 20 percent commission on signups tracked through a discount code. Roseland Lashay's 19 Mochi Health deals and Lorraine Kamesha's 22 Orderly Meds deals are the named anchors in our GLP-1 data. Both run on code-driven attribution with a hybrid base.
Next issue, every Monday
We found the best performing creators for May 25 → May 31.Hand-picked, not the same five names.
Plus the Influencer Advisory Consultant GPT.